Or if you're already a Pharma IQ member, sign in below to download. Sign In Join
It is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and novelty, are notoriously difficult to patent and litigate. In this podcast Dr. Alpesh Pathak, Head - Patent Cell at Alembic Research Center, shares his insights with Andrea Charles from Pharma IQ, regarding the IP landscape for pharmaceutical crystalline and polymorphic forms. Pathak also discusses the unique challenges surrounding patenting pharmaceutical crystalline and polymorphic forms and how the industry is responding to these issues.